Polyrizon

Polyrizon Enterprise Value

The Enterprise Value (EV) of Polyrizon (PLRZ) as of Oct 21, 2026 is 7.68 M USD. In the previous year, Enterprise Value (EV) was 17.40 M USD — a change of -55.86% (lower).

Enterprise Value

7.68 MUSD

YoY

-55.86%

Last updated:

Enterprise Value (EV) of Polyrizon is 2025 7.68 M USD. Enterprise Value (EV) of Polyrizon was 2024 17.40 M USD. It decreases by -55.86% lower compared to the previous year.

The Polyrizon Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2020
19.94 M USD
Jan 1, 2021
19.43 M USD
Jan 1, 2022
20.54 M USD
Jan 1, 2023
20.11 M USD
Jan 1, 2024
17.40 M USD
Jan 1, 2025
7.68 M USD
The Polyrizon Enterprise Value history
YEAREnterprise ValueYoY
7.68 MUSD-55.86%
17.40 MUSD-13.49%
20.11 MUSD-2.08%
20.54 MUSD+5.71%
19.43 MUSD-2.57%
19.94 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Polyrizon Stock analysis

What does Polyrizon do? Polyrizon Ltd develops medical device hydrogels delivered as nasal sprays that form a thin barrier in the nasal cavity to block viruses and allergens. The company specializes in creating a biological mask using naturally occurring building blocks, focusing on both product development and commercialization. Medical specialists and researchers collaborate with Polyrizon Ltd to advance their intranasal solutions. The firm's primary revenue comes from the development and commercialization of its nasal spray hydrogel products. These products target healthcare providers and consumers seeking protection against viral and allergen exposure. By forming a shield containment barrier, Polyrizon Ltd offers a solution that complements existing health measures without requiring additional equipment. Polyrizon Ltd's business model centers on the creation of a unique nasal barrier technology. The company leverages its focus on intranasal delivery to address market needs for non-invasive protection. Its collaboration with medical specialists ensures that its products meet clinical standards and user requirements. Polyrizon is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Polyrizon stock

Enterprise Value (EV) of Polyrizon is 7.68 M USD in 2025.

Enterprise Value (EV) of Polyrizon changed from 17.40 M USD to 7.68 M USD, representing a -55.86% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Polyrizon since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s USD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' USD varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Polyrizon with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Polyrizon

All Key Metrics — Polyrizon